Learning from ibogaine fatalities, rather than covering them up - greater political scrutiny leads to more transparency about harms

Ibogaine fatalities and serious harms need transparency and accountability rather than cover ups in the unregulated psychedelic market. The piece links recent Mexico incidents to a shift toward public scrutiny, including a death connected to an ibogaine detoxification program at the Ambio clinic in Baja and another serious incident at Transcend in Cancun. It also cites reported fatality disclosures by other clinics, and explains how opioid detection uncertainty and timing of administration may increase risk, including potentiation of existing opioids. It argues that secrecy creates a second harm for victims and families, and describes alleged patterns of minimization in parts of the iboga and ibogaine retreat ecosystem, with examples from Costa Rica and discussion of broader legal and safety weaknesses that transparency could help address.